|
|
||||||||||
|
J Am Coll Cardiol, 2006; 47:620-625, doi:10.1016/j.jacc.2005.08.071
(Published online 13 January 2006). © 2006 by the American College of Cardiology Foundation |




* Cardiovascular Centre Aalst, OLV-Clinic, Aalst, Belgium
Department of Cardiology, Catharina Hospital Eindhoven, Eindhoven, the Netherlands
Department of Nephrology, University of Ghent, Ghent, Belgium
Department of Epidemiology, OLV-Clinic, Aalst, Belgium
Manuscript received June 22, 2005; revised manuscript received July 25, 2005, accepted August 8, 2005.
* Reprint requests and correspondence: Dr. Bernard De Bruyne, Cardiovascular Center Aalst, OLV-Clinic, Moorselbaan, 164, B-9300 Aalst, Belgium (Email: bernard.de.bruyne{at}olvz-aalst.be).
OBJECTIVES: The purpose of this work was to establish the normal range of maximal renal hyperemic response in humans and to identify the ideal renal vasodilatory stimuli.
BACKGROUND: Stenotic renovascular atherosclerosis is increasingly treated by percutaneous transluminal renal intervention but with an unpredictable outcome. This may be due to hemodynamically non-significant stenosis or the presence of irreversible damage to the glomerular circulation. We propose that the renovascular hyperemic response may help identify appropriate patients.
METHODS: In 28 normotensive patients, quantitative angiographic measurements of the renal artery were obtained, and renal artery pressure and flow velocity were continuously recorded after various hyperemic agents.
RESULTS: In a first group of 11 patients, a significant increase in renal artery average peak velocity (APV) was observed after intrarenal (IR) bolus injection of 600 µg isosorbide dinitrate (41 ± 19%), 30 mg papaverine (50 ± 34%), 50 µg dopamine (94 ± 54%), 0.8 µg·kg1 fenoldopam (80 ± 25%), and during IR infusion of 1 µg·kg1·min1 fenoldopam (86 ± 28%). A second group of 17 patients received intravenous infusion of dopamine (3, 5, 10, 20, 30, and 40 µg·kg1·min1). The 3 and 5 µg·kg1·min1 of dopamine modestly reduced renal resistance index (RI) (13 ± 15% and 25 ± 20%, respectively). At higher dosages, no further decline in RI was observed. No significant change in vessel diameter was observed before and after the administration of the pharmacological stimuli suggesting that changes in APV corresponded with changes in absolute renal blood flow.
CONCLUSIONS: The normal renal flow reserve averages approximately 2 in humans with normal renal function. An IR bolus injection of 50 µg·kg1 of dopamine is the most convenient means to elicit maximal renal hyperemia.
| ||||||||||
This article has been cited by other articles:
![]() |
E. Mahmud, T. W.R. Smith, V. Palakodeti, O. Zaidi, L. Ang, C. R. Mitchell, N. Zafar, G. Bromberg-Marin, S. Keramati, and S. Tsimikas Renal Frame Count and Renal Blush Grade: Quantitative Measures That Predict the Success of Renal Stenting in Hypertensive Patients With Renal Artery Stenosis J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 286 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mockel, M. Radovic, Y. Kuhnle, V. Combe, J. Waigand, S. Schroder, R. Dietz, U. Frei, and K.-U. Eckardt Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1588 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Kuipers, C. L. Sauder, M. L. Kearney, and C. A. Ray Changes in forearm muscle temperature alter renal vascular responses to isometric handgrip Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3432 - H3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, O. Ben-Yehuda, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, J. Narula, D. J. Sahn, et al. Highlights of the Year in JACC 2006 J. Am. Coll. Cardiol., January 30, 2007; 49(4): 509 - 527. [Full Text] [PDF] |
||||
![]() |
W. F. Fearon Physiologic Assessment of Renal Artery Stenosis: Will History Repeat Itself? J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1856 - 1858. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |